DACS
TDOC icon

Dymon Asia Capital (Singapore)’s Teladoc Health TDOC Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,370
Closed -$1.04M – 162
2022
Q1 		$1.04M Sell
14,370
-28,100
-66% -$2.02M 0.07% 85
2021
Q4 		$3.9M Sell
42,470
-39,176
-48% -$4.68M 0.4% 42
2021
Q3 		$10.4M Buy
81,646
+60,410
+284% +$8.8M 1.14% 13
2021
Q2 		$3.53M Buy
21,236
+11,935
+128% +$1.93M 0.37% 43
2021
Q1 		$1.69M Buy
+9,301
New +$2.16M 0.12% 73

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s TDOC Position: Q2 2022 in Review

Dymon Asia Capital (Singapore) sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 14,370 shares — an estimated $1.04M sold.

Dymon Asia Capital (Singapore) first reported a position in TDOC in Q1 2021 and held it in 5 quarters. The position peaked at $10.4M in Q3 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Dymon Asia Capital (Singapore) reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Dymon Asia Capital (Singapore) sold 14,370 Teladoc Health shares in Q2 2022, an estimated $1.04M.
  • Dymon Asia Capital (Singapore) first reported a position in Teladoc Health in Q1 2021 and held it in 5 quarters.
  • Dymon Asia Capital (Singapore)'s Teladoc Health position peaked at $10.4M in Q3 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2022, filed 12 Aug 2022.